About
Omega Ophthalmics is a medical device company focused on developing and commercializing advanced ophthalmic technologies. Their flagship product, the Gemini Refractive Capsule, aims to improve outcomes in refractive surgery by maintaining the capsular bag in an open configuration and providing a stable position for an intraocular lens. This technology is designed to enhance long-term refractive stability and enable future ophthalmic innovations.
Key facts
At-a-glance profile data
- Website
- omega-ophthalmics.com
- Headquarters
- Lexington, United States
- Founded
- 2018
- Employees
- 6
- Total funding
- $7M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Aug 2026 | Series A | $7M | - |
Frequently asked
What is Omega Ophthalmics, LLC's Effective Domain Rating?
StartupHub's Effective Domain Rating for Omega Ophthalmics, LLC is 0 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is fairly rated against its Ahrefs Domain Rating of 0.
Is Omega Ophthalmics, LLC trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Omega Ophthalmics, LLC is 20 out of 100, based on site security posture and privacy practices.
How much funding has Omega Ophthalmics, LLC raised?
Omega Ophthalmics, LLC has raised a total of $7M in funding. The most recent round on record is Series A.
How many employees does Omega Ophthalmics, LLC have?
Omega Ophthalmics, LLC has approximately 6 people on record.
What is Omega Ophthalmics, LLC's current status?
Omega Ophthalmics, LLC's current operating status is: Inactive.